These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 3923578)

  • 1. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary anomalies of purine metabolism. Current biochemical aspects].
    Perignon JL; Cartier P
    Arch Fr Pediatr; 1980 Oct; 37(8):487-90. PubMed ID: 6255885
    [No Abstract]   [Full Text] [Related]  

  • 3. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 5. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders associated with purine and pyrimidine metabolism.
    Edwards NL; Fox IH
    Spec Top Endocrinol Metab; 1984; 6():95-140. PubMed ID: 6098039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal models for abnormal purine metabolism].
    Morisaki T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():482-6. PubMed ID: 12629770
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic defects in human purine and pyrimidine metabolism.
    Boss GR; Seegmiller JE
    Annu Rev Genet; 1982; 16():297-328. PubMed ID: 6297375
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in the activity of adenosine deaminase and of purine nucleoside phosphorylase and in the sensitivity to deoxypurine nucleosides between subpopulations of mouse thymocytes.
    Sidi Y; Umiel T; Trainin N; Pinkhas J; Sperling O
    Thymus; 1982 May; 4(3):147-54. PubMed ID: 6810516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes.
    Simmonds HA; Goday A; Morris GS; Brolsma MF
    Biochem Pharmacol; 1984 Mar; 33(5):763-70. PubMed ID: 6424679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inborn errors of purine catabolism.
    Van den Berghe G; Everaerts MC; Corbeel L
    Acta Paediatr Belg; 1981; 34(1):3-12. PubMed ID: 6267874
    [No Abstract]   [Full Text] [Related]  

  • 17. Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.
    Seegmiller JE
    Ann Rheum Dis; 1980 Apr; 39(2):103-17. PubMed ID: 6247984
    [No Abstract]   [Full Text] [Related]  

  • 18. First trimester diagnosis of Lesch-Nyhan syndrome: applications to other disorders of purine metabolism.
    Stout JT; Jackson LG; Caskey CT
    Prenat Diagn; 1985; 5(3):183-9. PubMed ID: 3927283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited disorders of purine metabolism--underlying molecular mechanisms.
    Gutensohn W
    Klin Wochenschr; 1984 Oct; 62(20):953-62. PubMed ID: 6209448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
    Carson DA; Seegmiller JE
    J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.